<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01113528</url>
  </required_header>
  <id_info>
    <org_study_id>HHDA-1962</org_study_id>
    <secondary_id>October 6 U 196222</secondary_id>
    <nct_id>NCT01113528</nct_id>
  </id_info>
  <brief_title>Omega-3 and Aspirin in Periodontal Regeneration</brief_title>
  <acronym>PR</acronym>
  <official_title>The Effect of Host Response Modulation Therapy (Omega 3 Plus Low-dose Aspirin) as an Adjunctive Treatment of Chronic Periodontitis (Clinical and Biochemical Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>October 6 University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>October 6 University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of systemic administration of omega 3 PUFA plus low dose aspirin as
      an adjunctive therapy to regenerative modality of grade II furcation defects in periodontitis
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we tested the hypothesis that the administration of omega 3 PUFA plus low dose
      aspirin would augment the results following regenerative therapy of furcation defects in
      chronic periodontitis patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cytokine levels</measure>
    <time_frame>six months</time_frame>
    <description>Interleukin-1 beta Interleukin-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gingival inflammation</measure>
    <time_frame>six months</time_frame>
    <description>plaque index Gingival index Gingival bleeding index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing after regenerative therapy</measure>
    <time_frame>six months</time_frame>
    <description>Probing pocket depth Clinical attachment level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Periodontal Disease</condition>
  <arm_group>
    <arm_group_label>Regenerative therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regenerative therapy (omega 3 PUFA plus low dose aspirin)</intervention_name>
    <description>Comparison between regenerative bone graft alone and bone graft + Omega-3 and low dose aspirin</description>
    <arm_group_label>Regenerative therapy</arm_group_label>
    <other_name>Omega</other_name>
    <other_name>Fish oil</other_name>
    <other_name>ASA</other_name>
    <other_name>low dose aspirin</other_name>
    <other_name>DFDBA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugar pill</intervention_name>
    <description>3 times daily</description>
    <arm_group_label>Sugar pill</arm_group_label>
    <other_name>Gelatinous capsules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  suffering moderate to sever chronic periodontitis and displaying at least a single
             grade II furcation defect according to Glickman's classification 1953, determined by
             both clinical and radiographic examinations;

          -  free from systemic diseases known to influence the periodontal condition and not
             receiving any medication known to affect the periodontal status;

          -  have not receive any periodontal therapy for a minimum of 6 months prior to the study.

        Exclusion Criteria:

          -  Known hypersensitivity or allergy to one of the used medications

          -  Pregnancy or lactation

          -  Heavy smoking (more than 10cigarretes/day)

          -  History of alcohol abuse

          -  Participation in other clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr M. Elkhouli, ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>October 6 University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>October 6 University</name>
      <address>
        <city>Cairo</city>
        <state>Overnorate of 6 October</state>
        <zip>part 1/1</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2010</study_first_submitted>
  <study_first_submitted_qc>April 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2010</study_first_posted>
  <last_update_submitted>May 13, 2010</last_update_submitted>
  <last_update_submitted_qc>May 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Amr Moustafa Elkhouli</name_title>
    <organization>Lecturer, O6U</organization>
  </responsible_party>
  <keyword>Bone allograft</keyword>
  <keyword>IL-1</keyword>
  <keyword>IL-10</keyword>
  <keyword>periodontal regeneration</keyword>
  <keyword>omega-3</keyword>
  <keyword>aspirin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingival Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

